Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
September 30, 2026 -571.9%
June 30, 2026 -315.0%
March 31, 2026 -253.5%
December 31, 2025 -199.0%
September 30, 2025 -110.6%
June 30, 2025 -258.1%
March 31, 2025 -63.94%
December 31, 2024 -254.1%
September 30, 2024 85.20%
June 30, 2024 -450.8%
March 31, 2024 -268.8%
December 31, 2023 -259.1%
September 30, 2023 -139.0%
June 30, 2023 -121.7%
Date Value
March 31, 2023 -153.0%
December 31, 2022 -91.25%
September 30, 2022 -188.6%
June 30, 2022 -74.36%
March 31, 2022 -70.89%
December 31, 2021 -83.45%
September 30, 2021 -72.41%
June 30, 2021 -19.61%
March 31, 2021 -39.33%
December 31, 2020 -42.96%
September 30, 2020 -57.17%
June 30, 2020 -60.36%
March 31, 2020 -46.23%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Agenus, Inc. 4.98%
Amgen, Inc. 37.29%
Anika Therapeutics, Inc. -1.02%
BioCryst Pharmaceuticals, Inc. 21.03%
Imunon, Inc. --